The high rate of preterm delivery in the United States is the greatest contributor to the relatively high infant mortality rate in this country. Despite much effort, no effective method exists for prevention of preterm delivery. Progesterone has been
Increased body fat levels are related to a large number of comorbid conditions, such as cardiac disease, diabetes, and cancer. Currently available drugs are useful but do not always bring about the desired goal. Weigle reviewed the past, present, and
Because doxorubicin is one of the most widely prescribed chemotherapy agents in oncology, family physicians are likely to have a number of cancer survivors in their patient panels who have received this medicine. Study results have shown that doxorubi
The number of patients with type 2 diabetes who are treated with insulin is likely to increase rapidly. A variety of insulin compounds and regimens are available, which allows for individualized therapy but complicates the process of establishing the
Computed tomography (CT) and positron-emission tomography (PET) commonly are used in the initial staging of lung cancer and other malignancies. While CT can provide excellent detail on the size and location of tumor masses and adjacent lymph nodes, it
Radiographic studies generally are ordered when children present with extremity injuries, including knee injuries. The Ottawa knee rule is highly sensitive in detecting clinically significant knee fractures. Application of this rule has reduced the ra
Many physicians use a white blood cell count to screen for infection in infants with fever. Studies have found that white blood cell count analysis is not accurate in screening infants for bacterial meningitis and urinary tract infection; its efficacy
The World Health Organization in 1998 suggested using the term "metabolic syndrome" to describe the combination of atherosclerotic risk factors that includes insulin resistance, microalbuminuria, hypercoagulability, dyslipidemia, obesity, and hyperten
Treatment strategies for patients with asthma and chronic obstructive pulmonary disease (COPD) include the use of inhaled corticosteroids. These inhaled agents have been shown to reduce inflammation, improve symptoms, and reduce exacerbations in patie
Metabolic syndrome is defined as obesity, insulin resistance, dyslipidemia, and hypertension. Persons who have the syndrome are at increased risk for adverse coronary events and stroke. Aggressive management can decrease mortality. Wong and associates
Author: Bill Zepf
Date: March 1, 2003
Typically, management of atrial fibrillation involves pharmacologic or electric maneuvers to convert the patient back to sinus rhythm. Adverse effects from antiarrhythmic drugs and recurrence of fibrillation dilute the benefits of cardioversion. Wyse and colleagues, writing for the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) trial, compared outcomes in atrial fibrillation with rate control alone and attempted restoration of sinus rhythm.
The investigators sought to enroll patients with atrial fibrillation who also had other cardiovascular risk factors and were deemed more likely to be at risk for long-term recurrence of fibrillation and stroke or death. Of the initial 7,401 patients classified as eligible at screening, 4,060 patients (55 percent) enrolled. The average age of participants was about 70 years. Of the 3,311 patients with echocardiograms, most had a dilated left atrium, but the majority had preserved left ventricular systolic function.
Participants were randomized to rate control alone (via beta blocker, calcium channel blocker, digoxin, or combinations of these drugs) or rhythm control (with antiarrhythmic drugs such as amiodarone or sotalol, used per specified guidelines, and electric cardioversion as necessary). Anticoagulation with warfarin was maintained throughout follow-up in the rate-control group but could be stopped after four to 12 weeks of restored sinus rhythm in the rhythm-control group. Rate control aimed for a resting pulse of no more than 80 beats per minute. The prevalence of sinus rhythm in the rhythm-control group declined from 82.4 percent at one year to 62.6 percent after five years.
After five years of follow-up, there was no significant difference in mortality between the group relying on rate control alone and the group using attempted rhythm control. The rate of stroke (6.3 percent overall) was not different between the two groups, and most events occurred when a patient was not taking warfarin or had a subtherapeutic International Normalized Ratio (INR) of less than 2.0. Rhythm-control patients had a trend toward more hospitalizations (80.1 percent) compared with rate-control subjects (73 percent), and about one third of rhythm-control patients crossed over during the study to rate control because of adverse effects or ineffective antiarrhythmic therapy.
The authors conclude that attempted rhythm control in patients with atrial fibrillation is not associated with a survival benefit or decreased stroke incidence compared with rate control alone and carries higher risks of drug-related adverse effects.
EDITOR'S NOTE: The same issue of the journal contains a report from a smaller European trial of 522 patients with persistent atrial fibrillation after cardioversion. Each patient received treatment aimed at rate or rhythm control. This study also showed no mortality benefit and no decrease in cardiovascular morbidity when comparing rhythm control with rate control alone. Before consigning rhythm control to obsolescence, however, readers should know that subanalysis of the AFFIRM data for relatively younger patients (younger than 65 years) did show a modest survival benefit. In addition, some fibrillation patients will always merit attempts at rhythm control on symptomatic grounds (e.g., congestive heart failure, decreased exercise tolerance).--B.Z.
Bill ZepfWyse DG, et al. A comparison of rate control and rhythm controlin patients with atrial fibrillation. The Atrial FibrillationFollow-up Investigation of Rhythm Management Investigators (AFFIRM).N Engl J Med December 5, 2002;347:1825-33, and Van GelderIC, et al. A comparison of rate control and rhythm controlin patients with recurrent persistent atrial fibrillation.N Engl J Med December 5, 2002; 347:1834-40.COPYRIGHT 2003 American Academy of Family PhysiciansCOPYRIGHT 2003 Gale Group